2024-11-18 21:25:26
Adlai Nortye Announces First Patient Dosed in Phase 1b Clinical Trial of AN0025 (EP4 Antagonist) in Combination with Merck's KEYTRUDA® (pembrolizumab) for Advanced Solid Tumors
Health/ 2023-07-22
Adlai Nortye Announces First Patient Dos...

NORTH BRUNSWICK,N.J.,Aug. 24,2020-- Adlai Nortye Ltd. ("Adlai Nortye"),a global clinical-stage biopharmaceutical company today ann...

Koichiro Matsumoto Appointed President/CEO of Bushu Pharmaceuticals Ltd.
Health/ 2023-07-22
Koichiro Matsumoto Appointed President/C...

KAWAGOE,Japan,Aug. 18,2020-- In response to requests for a professional contract development and manufacturing organization (CDMO) partner i...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release